IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FREDI, MICAELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.777
AS - Asia 3.603
EU - Europa 2.642
SA - Sud America 714
Continente sconosciuto - Info sul continente non disponibili 238
AF - Africa 114
OC - Oceania 10
Totale 16.098
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.468
SG - Singapore 1.284
CN - Cina 973
IT - Italia 627
BR - Brasile 587
DE - Germania 429
HK - Hong Kong 420
UA - Ucraina 379
VN - Vietnam 267
BD - Bangladesh 219
GB - Regno Unito 212
FR - Francia 199
FI - Finlandia 196
RU - Federazione Russa 169
CA - Canada 141
TR - Turchia 131
IE - Irlanda 108
IN - India 88
PL - Polonia 82
MX - Messico 55
AR - Argentina 46
SE - Svezia 46
ZA - Sudafrica 37
IQ - Iraq 33
NL - Olanda 29
PK - Pakistan 28
ES - Italia 26
AT - Austria 22
EC - Ecuador 22
ID - Indonesia 22
JP - Giappone 18
MA - Marocco 18
HN - Honduras 17
TT - Trinidad e Tobago 17
CR - Costa Rica 16
SV - El Salvador 16
CO - Colombia 15
LT - Lituania 15
BE - Belgio 14
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
PH - Filippine 13
IL - Israele 12
PR - Porto Rico 12
VE - Venezuela 12
KE - Kenya 11
PY - Paraguay 11
SC - Seychelles 11
AE - Emirati Arabi Uniti 9
AL - Albania 9
AU - Australia 9
JM - Giamaica 9
PT - Portogallo 9
UZ - Uzbekistan 9
KZ - Kazakistan 8
NG - Nigeria 8
DZ - Algeria 7
MK - Macedonia 7
NP - Nepal 7
AZ - Azerbaigian 6
ET - Etiopia 6
GR - Grecia 6
NI - Nicaragua 6
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
EG - Egitto 5
GT - Guatemala 5
JO - Giordania 5
MY - Malesia 5
NO - Norvegia 5
PE - Perù 5
RS - Serbia 5
CH - Svizzera 4
DK - Danimarca 4
EE - Estonia 4
KR - Corea 4
LV - Lettonia 4
TH - Thailandia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
GP - Guadalupe 3
LB - Libano 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AO - Angola 2
BM - Bermuda 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GY - Guiana 2
LU - Lussemburgo 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
Totale 15.842
Salva come PNG Salva come JPEG
Città #
Ashburn 784
Fairfield 717
Singapore 709
San Jose 515
Woodbridge 482
Hong Kong 416
Council Bluffs 346
Houston 314
Jacksonville 289
The Dalles 275
Cambridge 266
Beijing 248
Seattle 241
Wilmington 232
Chandler 220
Los Angeles 219
Chicago 215
Ann Arbor 213
New York 208
Princeton 175
Helsinki 143
Dallas 121
Dublin 108
Lauterbourg 108
Istanbul 104
Columbus 84
Ho Chi Minh City 83
Salt Lake City 82
Warsaw 78
Santa Clara 77
Munich 76
Brescia 71
Nanjing 69
Buffalo 64
Hanoi 60
Phoenix 53
Milan 52
San Francisco 51
Moscow 48
North Bergen 48
Shanghai 48
São Paulo 48
Redondo Beach 45
London 42
San Diego 40
Orem 36
Rome 35
Des Moines 34
Montreal 34
Atlanta 33
Nuremberg 33
Elk Grove Village 32
Nanchang 32
Tampa 31
Lancaster 28
Turku 28
Brooklyn 26
Changsha 25
Shenyang 25
Johannesburg 24
Toronto 23
Chennai 22
Denver 22
Hebei 22
Mexico City 22
Tianjin 21
Miami 20
Cagliari 18
Romola 18
Tokyo 18
Ottawa 17
Washington 17
Frankfurt am Main 16
Jiaxing 16
Bergamo 15
Brasília 15
Naples 15
Brussels 14
Manchester 14
Porto Alegre 14
San José 13
San Salvador 13
Belo Horizonte 12
Charlotte 12
Dong Ket 12
Haiphong 12
Jinan 12
Rio de Janeiro 12
Stockholm 12
Amsterdam 11
Bologna 11
Da Nang 11
Hangzhou 11
Sterling 11
Verona 11
Vienna 11
Biên Hòa 10
Dearborn 10
Dhaka 10
Dulles 10
Totale 9.929
Salva come PNG Salva come JPEG
Nome #
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 721
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 254
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 253
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 229
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 214
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 205
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 202
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 200
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 197
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 193
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 193
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 191
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 190
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 187
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 187
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 183
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 183
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 180
Antiphospholipid antibodies mediate autoimmunity against dying cells. 179
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 177
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 171
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 171
The clinico-serological spectrum of overlap myositis 168
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 167
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 165
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 165
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 162
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 160
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 157
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 156
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 153
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 152
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 150
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 150
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 149
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 149
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 149
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 147
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 143
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 142
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 141
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 140
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 138
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 137
Myositis autoantibodies and clinical phenotypes 137
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 136
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 136
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 135
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 135
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 133
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 133
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 133
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 133
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 131
Autoimmune polyglandular syndrome type 4: experience from a single reference center 128
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 125
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 121
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 120
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 118
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 118
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 118
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 116
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 114
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 112
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 111
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 111
Should we treat congenital heart block with fluorinated corticosteroids? 110
Managing puerperium in patients with systemic autoimmune diseases: an update 110
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 107
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 107
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 107
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 106
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 106
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 105
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 105
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 105
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 103
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 102
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 101
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 100
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 100
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 98
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 98
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 98
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 97
Neutrophil Extracellular Traps in the Autoimmunity Context. 96
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 96
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 93
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 90
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 89
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 88
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 87
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 86
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 84
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 82
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 81
Systemic lupus erythematosus: state of the art on clinical practice guidelines 81
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 80
Clinical phenotype of Graves' disease in Autoimmune Polyglandular Syndrome or as isolated disease: the GRAPHE study 80
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation 79
Totale 14.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022531 0 0 0 0 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/20252.702 23 38 40 238 195 186 144 92 222 209 579 736
2025/20264.868 402 618 325 672 470 322 685 174 253 454 256 237
2026/20272.016 222 269 378 841 306 0 0 0 0 0 0 0
Totale 16.098